Opposition procedure before the European Patent Office


Opposition procedure before the European Patent Office

The opposition procedure before the European Patent Office (EPO) is a post-grant, contentious, inter partes, administrative [1] procedure intended to allow any European patent to be centrally opposed. European patents granted by the EPO under the European Patent Convention (EPC) may be opposed by any person from the public (no commercial or other interest whatsoever need be shown). This happens often when some prior art was not found during the grant procedure, but was only known by third parties.

The opposition can only be based on grounds mentioned in Article 100 EPC,[2] i.e. on the grounds that the subject-matter of the patent is not patentable, on the grounds that the invention is not sufficiently described to allow a person skilled in the art to carry it out, or on the grounds that the content of the patent extends beyond the content of the application as filed.

The notice of opposition must be filed in writing at the EPO (either at Munich, The Hague or Berlin) within nine months from the publication of the mention of the grant of the European patent, along with the payment of an opposition fee. Opposition divisions of the EPO are then responsible for the opposition procedure. The opposition procedure may involve multiple opponents. According to the EPO, a European patent was once opposed by a record number of 27 opponents.[3]

Contents

Rationale

The purpose of the opposition proceedings is to give opponents the opportunity to challenge the validity of a granted European patent.[4]

Filing and admissibility

Before starting the substantive examination of the opposition, the Opposition Division examines whether the opposition must be considered as filed ("Is there an opposition?") and whether it is admissible ("Is the opposition admissible?"). The Opposition Division may find that the opposition is not deemed to have been filed, for instance because the opposition fee has not been paid within the nine-month opposition period, because the notice of opposition is not signed or because the notice is not in an accepted language.[5]

In order for an opposition to be admissible it must meet the provisions of[6]

  • Article 99(1) EPC, i.e. a notice of opposition must be filed within nine months from the publication of the mention of grant of the European patent by a natural or legal person, and
  • Rule 76(2)(c) EPC,[7] i.e. a statement of the extent to which the European patent is opposed and of the grounds on which the opposition is based must be contained in the notice of opposition, as well as an indication of the facts and evidence presented in support of these grounds.

In addition, an opposition is also rejected as inadmissible if it fails to meet the requirements of Rule 76(2)(a), (b) and (d) EPC[8] after the opponent was invited to remedy to these failures within a given time limit. If the opposition is not admissible, the opposition is rejected under Rule 77(1) or (2) EPC.[9]

Inadmissible oppositions and oppositions which are deemed not to have been filed are not substantively examined (no examination on the merits). An opposition can only be rejected as inadmissible if the opposition has been first deemed to have been filed, and, if it is deemed to have been filed, the opposition exists, even if later the opposition is rejected as inadmissible. If an opposition is deemed not to have been filed, an already paid opposition fee is refunded. In contrast, if an opposition is rejected as inadmissible, an already paid opposition fee is not refunded.[10]

Substantive examination

Buildings of the EPO (on both sides of the Kurt-Haertel-Passage, Munich, Germany) where notably some oppositions are examined.

If the opposition is admissible, the grounds for opposition are examined as to their merits.[11] The patent proprietor has also the opportunity to reply to the grounds of opposition developed by the opponent. Arguments and, to a certain extent,[12] amendments may be filed in reply by the patent proprietor.

In view of the grounds of opposition, and in view for instance of a prior art document introduced into the proceedings by the opponent, the patent proprietor may amend the patent, i.e. the description, claims and drawings of the patent.[12] The patent proprietor is master of its own patent in that the decision to amend or not, and how to amend the patent, is a decision of the patent proprietor alone (although the Opposition Division or the opponent may apply pressure to have amendments made).[13] The patent, however, may not be amended in such a manner that the amendment would lead to an extension of the protection conferred by the patent.[14]

If amendments are made to the patent during the opposition proceedings, the patent (and the invention to which it relates) must meet the requirements of the EPC.[15] These requirements notably include the requirements of support in the description and clarity (Article 84 EPC), even though those are not listed as grounds of opposition in Article 100 EPC.[16] However, the requirements to be met by the amended patent do not include the requirement of unity of invention (because divisionals cannot be filed after grant).[17]

During the opposition, oral proceedings may take place at the request of the EPO or at the request of any party to the proceedings, i.e. the patentee or an opponent.[18] The oral proceedings are held before the Opposition Division itself.[19] They are held in Munich, the Hague or Berlin, and are public unless very particular circumstances apply.[20] This contrasts with oral proceedings held before an Examining Division, which are not public.[21] The list of public oral proceedings in opposition before the EPO is available on its web site.[22] The right to oral proceedings is a specific and codified part of the procedural right to be heard.[23] A decision is often taken at the end of the oral proceedings.

Issue and effects of the opposition

After the end of the opposition proceedings, the patent is either

  • maintained as granted, that is, the opposition is rejected;[24]
  • maintained in an amended form.[25] In this case, a new patent specification is published; or
  • revoked.[26]

The opposition has effect on all designated states in the European patent. Decisions by Opposition Divisions, like any other final decisions of first instance divisions, are appealable.[27]

A decision of the EPO to revoke a European patent is final (when the opportunity to appeal before the EPO is exhausted), which makes the opposition proceedings at the EPO especially attractive for opponents.[28] In contrast, a decision of the EPO not to revoke a European patent (the decision instead maintaining the patent as granted or in an amended form) leaves the way open for revocation by the national court. The EPO decision does not create an estoppel precluding a subsequent challenge by an unsuccessful opponent at the national level (at least before the English courts).[29] The validity of a European patent can be scrutinised both at the national level, before a national court, and at the international level, before the European Patent Office during opposition. The same is not true for infringement proceedings, upon which national courts exercise exclusive jurisdiction.

Apportionment of costs

Each party to the opposition proceedings normally bears the costs it has incurred, unless the Opposition Division (or, in appeal proceedings, the Board of Appeal under Rule 100(1) EPC[30]), for reasons of equity, orders a different apportionment of costs.[31] For example, in case T 1306/05, a highly relevant document had been lately filed, without any valid justification, by the opponent during the oral proceedings before the Board of Appeal, thus rendering useless both the oral proceedings and the patent proprietor preparation thereto.[32] A different apportionment of costs has been ordered by the Board of Appeal. The patent proprietor has requested [33] about €26,000 to be paid by the opponent.[34]

A decision on apportionment of costs forms part of the main decision, such as the main decision of the Opposition Division. The main decision however only deals with the obligation on the party or parties concerned to bear costs. The actual amounts to be paid by one party to another are dealt with in another decision, namely a decision on the award of costs.[35] A decision on the award of costs is taken only after a decision apportioning the costs has been taken and if a request is submitted to that effect.[36]

Transfer of opponent status

The opponent status cannot be freely transferred.[37][38] As far as legal persons are concerned, the opposition can only be transferred or assigned to a third party together with the business assets belonging to a company, i.e. its economic activity, and more precisely the assets in the interests of which the opposition was filed.

Intervention and observations by third parties

Under Article 105 EPC, any third party may intervene in opposition proceedings after the 9-month opposition period has expired, if the third party proves that "(a) proceedings for infringement of the same patent have been instituted against him, or (b) following a request of the proprietor of the patent to cease alleged infringement, the third party has instituted proceedings for a ruling that he is not infringing the patent."[39] The admissibility of an intervention is subject to conditions.[40] The so-called notice of intervention must notably be filed within three months of the date on which proceedings referred to in Article 105 are instituted.[41] An admissible intervention is treated as an opposition.[42] If the intervention is admissible, the intervener becomes party to the opposition proceedings.

The possibility to intervene not only exists during pending opposition proceedings before an Opposition Division (i.e., during the first instance proceedings), but also during subsequent pending appeal proceedings before a Board of Appeal (i.e., during the second instance proceedings).[43]

Independently from the possibility to intervene in opposition proceedings (and then to become party to the proceedings), anyone may also file observations under Article 115 EPC. After publication of a European patent application, and a fortiori after grant of a European patent, anyone may file observations regarding the patentability of the invention which is the subject of the application (during examination proceedings) or patent (during opposition proceedings).[44] In contrast to an intervener however, a person filing observations during opposition proceedings does not become party to the proceedings.[44] This notably means that such person does not acquire the "bundle of procedural rights" created "in respect of the opponent", such as the right to be heard before any decision is taken.[45] Observations by third parties, which must be filed in writing,[46] may be filed by post or online.[47]

Statistics, costs and duration

Overall, about 6% of the European patents granted by the European Patent Office are opposed.[28][48] Of those, about 1/3 are revoked, 1/3 are maintained in an amended form, which generally means "reduced in scope", and 1/3 are maintained as granted, that is, the opposition is rejected. The opposition rate (i.e. the number of oppositions filed per 100 granted patents) before the EPO is consistently higher in the closest available proxy for the pharmaceutical sector than it is in organic chemistry and in all sectors (overall EPO average).[49]

Filing an opposition before the EPO is reportedly relatively affordable, "as the cost varies between €6000 and €50,000 (including patent lawyers’ fees)"[28] (as of 2009). In contrast, the costs for litigating a European patent can be much higher ("For example, in Germany the total litigation costs can be as high as €2 million with €10 million at stake"[28]). An opposition case is reported to take on average three years to be handled by the EPO.[28]

Parallel national proceedings

The "possibility of parallel validity proceedings in national courts and in the EPO is inherent in the legal arrangements in the EPC under which the EPO was established".[29] If a third party files an opposition to a European patent with the EPO and also, in parallel, initiates a revocation action (also called "nullity action" or "validity proceedings") against the same patent before a national court, the national court (at least in England) may exercise its discretion to either

  • stay the national proceedings, in order to wait the outcome of the EPO opposition proceedings, or
  • allow the revocation proceedings to go ahead, without waiting the outcome of the EPO proceedings.[29]

The rules and practice differ from country to country in that respect. "For example, as of 2008, Belgium and France will stay the main proceeding until a final decision has been reached by the EPO whereas in Germany, Italy, the Netherlands and in the United Kingdom such a stay is not automatic and in most cases the courts will continue the proceedings notwithstanding the opposition. ... However, in Germany national nullity proceedings cannot be started before the Federal Patent Court until the EPO opposition proceedings have been concluded or the opposition period has expired."[28]

Composition of an Opposition Division

According to Article 19(2) EPC, "[a]n Opposition Division shall consist of three technically qualified examiners, at least two of whom shall not have taken part in the proceedings for grant of the patent to which the opposition relates. An examiner who has taken part in the proceedings for the grant of the European patent may not be the Chairman." Violations of Article 19(2) EPC are considered to be substantial procedural violations.[50]

References and notes

  1. ^ "Proceedings at this level are called "administrative" rather than "judicial" though it is difficult to see why – after all the opposition division is deciding a dispute between rival parties." in Jacob LJ, Unilin Beheer BV v Berry Floor NV & Ors [2007] EWCA Civ 364 (25 April 2007).
  2. ^ "The function of Article 100 EPC is to provide, within the framework of the EPC, a limited number of legal bases, ie a limited number of objections on which an opposition can be based." in G 1/95 (19 July 1996), reasons 4.1.
  3. ^ European Commission Pharmaceutical Sector Inquiry, Preliminary Report - 28 November 2008, Comments from the EPO, 10.03.2009 (Final), page 5.
  4. ^ G9/93, 6 July 1994, Reasons, point 3.
  5. ^ Rule 3 EPC
  6. ^ Rule 77(1) EPC
  7. ^ Rule 76(2)(c) EPC (formerly Rule 55(c) EPC 1973)
  8. ^ Rule 76(2)(a), (b) and (d) EPC (formerly Rule 55(a), (b) and (d) EPC 1973)
  9. ^ Rule 77(1) or (2) EPC (formerly Rule 56(1) or (2) EPC 1973)
  10. ^ See e.g. Guidelines for Examination in the EPO d.iv.1.2 or Visser, "The Annotated European Patent Convention", ed. 2009, p. 227 (Art. 99(1), point 4 "Procedure after filing".).
  11. ^ Article 101(1) EPC
  12. ^ a b Rule 80 EPC
  13. ^ EPO Board of Appeal decision T 1099/06, Reasons 6.
  14. ^ Article 123(3) EPC
  15. ^ Article 101(3) EPC
  16. ^ See also decision T 936/04 of 24 April 2008 on whether the double patenting prohibition can be raised in opposition proceedings: "It is within the discretion of the instances of the EPO to raise the objection in opposition or opposition appeal proceedings against proposed amended claims, but this should be done only in clear cases" (catchword 1).
  17. ^ Enlarged Board of Appeal decision G 1/91 of 9 December 1991. The reference to Article 102(3) in the decision is a reference to Article 102(3) EPC 1973, corresponding to Article 101(3)(a) EPC (of the revised text of the Convention, the so-called EPC 2000).
  18. ^ Article 116(1) EPC
  19. ^ Article 19(2)(fourth sentence) EPC
  20. ^ Article 116(4) EPC
  21. ^ Article 116(3) EPC
  22. ^ EPO web site, Oral proceedings calendar. Consulted on April 30, 2008.
  23. ^ "The right to oral proceedings according to Article 116 EPC is a specific and codified part of the procedural right to be heard according to Article 113(1) EPC." in Decision T 1012/03 of December 1, 2006, Reasons 25.
  24. ^ Article 102(2) EPC
  25. ^ Article 102(3) EPC
  26. ^ Article 102(1), (4) and (5) EPC
  27. ^ Article 106 EPC
  28. ^ a b c d e f Malwina Mejer, Bruno van Pottelsberghe de la Potterie, "Economic Incongruities in the European Patent System", ECARES working paper 2009‐003, January 2009.
  29. ^ a b c Glaxo Group Ltd v Genentech Inc & Anor [2008] EWCA Civ 23 (31 January 2008)
  30. ^ See also Article 16 of the Rules of Procedure of the Boards of Appeal (RPBA)
  31. ^ Article 104 EPC
  32. ^ (French) Decision T 1306/05 of July 10, 2008, Boards of Appeal of the EPO.
  33. ^ Under Rule 88(2) EPC and Rule 100 EPC.
  34. ^ (French) Laurent Teyssedre, T1306/05 : répartition des frais, Le blog du droit européen des brevets, October 19, 2008. Consulted on November 8, 2008.
  35. ^ Guidelines for Examination in the EPO d.ix.1.2 .
  36. ^ Rule 88(2) EPC
  37. ^ Decision G 2/04 of 25 May 2005, Headnote I.(a).
  38. ^ EPO Board of Appeal decision T 0384/08 of 26 June 2009, Reasons 24.
  39. ^ Article 105(1) EPC
  40. ^ Rule 89 EPC
  41. ^ Rule 89(1) EPC
  42. ^ Article 105(2) EPC
  43. ^ Enlarged Board of Appeal decision G 1/94 (OJ 1994,787), point 10 of the decision.
  44. ^ a b Article 115 EPC
  45. ^ G4/88, 24 April 1989, Reasons, point 2.
  46. ^ Rule 114 EPC
  47. ^ Decision of the President of the European Patent Office dated 10 May 2011 concerning the filing of third party observations under Article 115 EPC by means of an online form, EPO Official Journal 7/2011, p. 418; Notice from the European Patent Office dated 10 May 2011 concerning the filing of third party observations under Article 115 EPC by means of an online form, EPO OJ 7/2011, p. 420.
  48. ^ EPO web site, CA/PL 29/99 dated 8.11.1999, Revision of the EPC: limitation procedure, in Travaux préparatoires 1997-2000, Patent Law Committee documents, item II.7.
  49. ^ European Commission, Pharmaceutical Sector Inquiry, Preliminary Report (DG Competition Staff Working Paper), 28 November 2008, pages 10-11 (pdf, 1.95 MB).
  50. ^ See for instance Board of Appeal decision T 1349/10 (Composition of Opposition Division/ETHICON) of 2 February 2, 2011, Reasons 4, citing also decisions T 251/88, T 939/91, T 382/92, T 476/95, and T 838/02.

See also

External links


Wikimedia Foundation. 2010.

Look at other dictionaries: